These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 22543946)

  • 21. Genetic testing in veterinary dermatology.
    Leeb T; Müller EJ; Roosje P; Welle M
    Vet Dermatol; 2017 Feb; 28(1):4-e1. PubMed ID: 27425028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Her2 amplification: correlation of chromogenic in situ hybridization with immunohistochemistry and fluorescence in situ hybridization.
    Wixom CR; Albers EA; Weidner N
    Appl Immunohistochem Mol Morphol; 2004 Sep; 12(3):248-51. PubMed ID: 15551739
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of ALK gene rearrangement in non-small cell lung cancer: a comparison of fluorescence in situ hybridization and chromogenic in situ hybridization with correlation of ALK protein expression.
    Kim H; Yoo SB; Choe JY; Paik JH; Xu X; Nitta H; Zhang W; Grogan TM; Lee CT; Jheon S; Chung JH
    J Thorac Oncol; 2011 Aug; 6(8):1359-66. PubMed ID: 21587085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring study.
    van de Vijver M; Bilous M; Hanna W; Hofmann M; Kristel P; Penault-Llorca F; Rüschoff J
    Breast Cancer Res; 2007; 9(5):R68. PubMed ID: 17922920
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contributions of Histopathology and Molecular Biology for the Discovery of Genodermatoses in Animals: Break the Codes!
    Nishifuji K
    Vet Pathol; 2015 Jul; 52(4):605-6. PubMed ID: 25653202
    [No Abstract]   [Full Text] [Related]  

  • 26. [Possibilities and limitations of molecular pathology in dermatohistology].
    Schacht V; Lehmann U; Reineke-Plaass T; Länger F; Auber B; Morlot S; Kreipe HH
    Hautarzt; 2018 Jul; 69(7):563-569. PubMed ID: 29876610
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The polymerase chain reaction. Applications in dermatology.
    Snow JL; Snow K; Pittelkow MR
    J Dermatol Surg Oncol; 1993 Sep; 19(9):831-45. PubMed ID: 8366219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Utility of chromogenic in situ hybridization (CISH) for detection of EGFR amplification in glioblastoma: comparison with fluorescence in situ hybridization (FISH).
    Fischer I; de la Cruz C; Rivera AL; Aldape K
    Diagn Mol Pathol; 2008 Dec; 17(4):227-30. PubMed ID: 18382350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chromogenic in situ hybridisation testing for HER2 gene amplification in breast cancer produces highly reproducible results concordant with fluorescence in situ hybridisation and immunohistochemistry.
    Bilous M; Morey A; Armes J; Cummings M; Francis G
    Pathology; 2006 Apr; 38(2):120-4. PubMed ID: 16581651
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of New Techniques in Addition to IHC Applied to the Diagnosis of Melanocytic Lesions, With Emphasis on CGH, FISH, and Mass Spectrometry.
    Nagarajan P; Tetzlaff MT; Curry JL; Prieto VG
    Actas Dermosifiliogr; 2017; 108(1):17-30. PubMed ID: 27344067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New and emerging dermatologic therapies presented at conference.
    Lamberg L
    JAMA; 2000 May; 283(18):2377-8. PubMed ID: 10815063
    [No Abstract]   [Full Text] [Related]  

  • 32. Chromogenic in situ hybridization (CISH) to detect HER2 gene amplification in breast and gastric cancer: comparison with immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH).
    Kiyose S; Igarashi H; Nagura K; Kamo T; Kawane K; Mori H; Ozawa T; Maeda M; Konno K; Hoshino H; Konno H; Ogura H; Shinmura K; Hattori N; Sugimura H
    Pathol Int; 2012 Nov; 62(11):728-34. PubMed ID: 23121603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.
    Schlemmer BO; Sorensen BS; Overgaard J; Olsen KE; Gjerdrum LM; Nexo E
    Scand J Clin Lab Invest; 2004; 64(5):511-22. PubMed ID: 15276916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescence in situ hybridization as an ancillary tool in the diagnosis of ambiguous melanocytic neoplasms: a review of 804 cases.
    North JP; Garrido MC; Kolaitis NA; LeBoit PE; McCalmont TH; Bastian BC
    Am J Surg Pathol; 2014 Jun; 38(6):824-31. PubMed ID: 24618603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EGFR status in oral squamous cell carcinoma: comparing immunohistochemistry, FISH and CISH detection in a case series study.
    Bernardes VF; Gleber-Netto FO; Sousa SF; Rocha RM; Aguiar MC
    BMJ Open; 2013 Jan; 3(1):. PubMed ID: 23358562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HER 2 status in invasive breast cancer: immunohistochemistry, fluorescence in-situ hybridization and chromogenic in-situ hybridization.
    Shirsat HS; Epari S; Shet T; Bagal R; Hawaldar R; Desai SB
    Indian J Pathol Microbiol; 2012; 55(2):175-9. PubMed ID: 22771638
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The changing face of cutaneous biology as seen from the National Institutes of Health.
    Moshell AN
    J Investig Dermatol Symp Proc; 2002 Dec; 7(1):4-5. PubMed ID: 12518786
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [What's new in dermatological research?].
    Dereure O
    Ann Dermatol Venereol; 2009 Dec; 136 Suppl 7():S407-16. PubMed ID: 20110056
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular diagnosis of Ewing sarcoma family of tumors: a comparative analysis of 560 cases with FISH and RT-PCR.
    Machado I; Noguera R; Pellin A; Lopez-Guerrero JA; Piqueras M; Navarro S; Llombart-Bosch A
    Diagn Mol Pathol; 2009 Dec; 18(4):189-99. PubMed ID: 19861898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Telemedical approach to the organization of the advisory dermatologic care].
    Beliakin SA; Barbinov VV; Patsenko GN; Vinogradov SN
    Voen Med Zh; 2014 Jun; 335(6):24-8. PubMed ID: 25286570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.